Clinical Trials on Asthma/ COPD in New Zealand

Total 1209 results

GlaxoSmithKline

Completed

Pharmacokinetic and Pharmacodynamic (PK and PD) Study of Fluticasone Propionate and Salmeterol Combination Product Delivered in a Capsule-based Inhaler and in a Multi-dose Dry Powder Inhaler in Moderate Asthma Patients and Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) Patients.

Asthma

Australia, New Zealand
Fisher and Paykel Healthcare

Completed

Efficacy of NIV Masks in COPD

COPD

New Zealand
Arrowhead Pharmaceuticals

Completed

Study of ARO-RAGE in Healthy Subjects

Asthma

New Zealand
GlaxoSmithKline

Completed

A Study in Asthmatic Patients to Determine if There is Any Difference in Dosing With Fluticasone Furoate/Vilanterol Inhalation Powder in the Morning or Evening on Lung Function

Asthma

New Zealand
Intech Biopharm Ltd.

Completed

A Bioequivalence Pivotal Study of SYN010 HFA Inhaler and Symbicort® 160/4.5 in Healthy Volunteers Without Charcoal Block

Asthma | COPD

Taiwan
GlaxoSmithKline

Completed

Spacer Comparison In Adult Asthmatics

Asthma

New Zealand
GlaxoSmithKline

Completed

A Study to Assess the Bronchodilator Effect of a Single Dose of Fluticasone Furoate (FF)/ Vilanterol (VI) 100/25 Micrograms (mcg) Combination When Administered in Adult Patients With Asthma

Asthma

New Zealand
GlaxoSmithKline

Completed

Single Dose GW685698X Magnesium Stearate Study In Asthmatic Patients.

Asthma

New Zealand
GlaxoSmithKline

Completed

This Study Will Examine the Effects of GSK256066 to Protect Mild Steroid-naive Asthmatics Against an Antigen Challenge

Asthma

New Zealand
GlaxoSmithKline

Completed

The Effect Of AVANDIA On The Late Asthmatic Response

Asthma

New Zealand
University of Otago

Completed

Does Improving Insulation and Heating Improve Health?

Asthma

New Zealand
Mylan Inc.
Theravance Biopharma

Completed

Effects of TD-4208 on FEV1 in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

Chronic Obstructive Pulmonary Disease, COPD

New Zealand
Mylan Inc.
Theravance Biopharma

Completed

7 Days of TD-4208 in Subjects With Chronic Obstructive Pulmonary Disease

COPD

New Zealand
GlaxoSmithKline

Completed

Study on the Effects of an AMP Challenge on Asthmatic Patients Following Treatment With Fluticasone Propionate

Asthma

New Zealand
University of Melbourne
Austin Health; Prince of Wales Hospital, Sydney; Burwood Hospital, Christchurch... and other collaborators

Completed

SCIPA Full-On :Intensive Exercise Program After Spinal Cord Injury (SCIPAFull-On)

Spinal Cord Injury

Australia, New Zealand
GlaxoSmithKline

Completed

A Phase IIA FF/VI Study to Measure FeNO in Asthmatic Patients.

Asthma

New Zealand
Fisher and Paykel Healthcare
Medical Research Institute of New Zealand; Alana Healthcare

Terminated

Nasal High Flow Therapy 30 Day Readmission Study (N3ADS)

Chronic Obstructive Pulmonary Disease | COPD

United States, New Zealand
University of Melbourne
Princess Alexandra Hospital, Brisbane, Australia; Prince of Wales Hospital,... and other collaborators

Completed

Early Intensive Hand Rehabilitation After Spinal Cord Injury (SCIPAHandsOn)

Spinal Cord Injury

Australia, New Zealand
GlaxoSmithKline

Completed

Study In Airway Physiology In Children SERETIDE DISKUS ® Inhlaer and FLIXOTIDE® Inhaler Are Trademarks of GSK Group of Companies.

Asthma

United Kingdom, New Zealand
AstraZeneca

Completed

A Study in Healthy Volunteers and Patients With Mild Asthma to Investigate the Safety, Anti-inflammatory Effect of Inhaled AZD0449

Asthma

New Zealand, United Kingdom
GlaxoSmithKline

Completed

Randomised Study Comparing the Effects of Inhaled FF/GW642444M Combination, FF and GW642444M on an Allergen Induced Asthmatic Response

Asthma

Sweden, Australia, New Zealand
GlaxoSmithKline

Completed

Clinical Endpoint Trial Investigating Once Daily and Bronchodilator Dosing

Asthma

New Zealand, South Africa
GlaxoSmithKline

Completed

Randomised Study Comparing the Effects of Inhaled Fluticasone Furoate (FF)/Vilanterol (VI; GW642444M) Combination and FF on an Allergen Induced Asthmatic Response

Asthma

United Kingdom, Germany, New Zealand
Rex Bionics Plc
Generic Devices Consulting, Inc.

Completed

Safety and Feasibility Evaluation of Robot Assisted Physiotherapy Exercises With REX (RAPPER II)

Spinal Cord Injury

Australia, United Kingdom, New Zealand
University of Otago

Completed

Housing, Insulation and Health Study (HIHS)

Asthma | Respiratory Illness

New Zealand
Intech Biopharm Ltd.

Completed

Bioequivalence Study of Synflutide HFA Inhaler and Seretide Evohaler in Healthy Volunteers With Charcoal Block

Asthma | Chronic Obstructive Pulmonary Disease (COPD)

Taiwan
Aquinox Pharmaceuticals (Canada) Inc.

Completed

Efficacy and Safety of AQX-1125 in Unstable COPD (FLAGSHIP)

COPD

United States, New Zealand, Poland, Australia, Denmark, Finland, Hungary, Sweden
Intech Biopharm Ltd.

Completed

Bioequivalence Study of Synflutide HFA Inhaler and Seretide Evohaler in Healthy Volunteers Without Charcoal Block

Asthma | Chronic Obstructive Pulmonary Disease (COPD)

Taiwan
Naestved Hospital

Recruiting

Implementation of Evidence-based Breathing Retraining for Patients With Asthma in Region Zealand (EmBRAiZ)

Asthma

Denmark
RWTH Aachen University

Completed

Inhalation Therapy in Ambulant and Hospitalized Patient Using Available Film Sequences From the Internet (InhaliPAD)

Asthma | COPD | Obstructive Lung Disease

Germany
James J. Peters Veterans Affairs Medical Center

Completed

Exhaled Breath Condensate Biomarkers of Inflammation in Individuals With Chronic Cervical Spinal Cord Injury

Asthma | Tetraplegia

United States
Weill Medical College of Cornell University

Completed

Evaluation of the Lungs of Individuals With Lung Disease

Asthma | Emphysema | Lung Disease | Bronchitis | COPD

United States
Merck Sharp & Dohme LLC

Completed

Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MK-1029 in Participants With Mild to Moderate Asthma

Asthma

United States, Australia, New Zealand, South Africa
Equillium
Biocon Limited; Equillium AUS Pty Ltd

Completed

A Study of Itolizumab (EQ001) to Evaluate the Safety, Tolerability, PK, PD, and Clinical Activity in Uncontrolled Asthma (EQUIP)

Asthma

New Zealand, Australia
State University of New York at Buffalo

Terminated

Repeat Emergency Department Visits Among Patients With Asthma and COPD

Asthma | COPD

United States
Icahn School of Medicine at Mount Sinai
National Heart, Lung, and Blood Institute (NHLBI)

Recruiting

Informatics Framework for Pulmonary Rehabilitation (CHIEF-PR)

COPD

United States
NYU Langone Health

Completed

Electronic Cigarettes as a Harm Reduction Strategy Among Patients With COPD

COPD

United States
Dartmouth-Hitchcock Medical Center
American Academy of Medical Acupuncture

Recruiting

Acupuncture to Enhance for Pulmonary Rehab

COPD

United States
Teva Branded Pharmaceutical Products R&D, Inc.

Terminated

Study in Healthy Volunteers and COPD Patients to Evaluate the Efficacy and Safety of Inhaled TV46017

Chronic Obstructive Pulmonary Disease (COPD

United States, Australia, New Zealand
Chinese University of Hong Kong

Recruiting

Predicting Adverse Outcomes Using Machine Learning of COPD Patients in Hong Kong

COPD Exacerbation

Hong Kong
Weill Medical College of Cornell University
National Heart, Lung, and Blood Institute (NHLBI); Boehringer Ingelheim

Completed

Integrative-omics of the Disordered COPD Small Airway Epithelium

Smoking | COPD

United States
Weill Medical College of Cornell University

Terminated

COPD Metabolome, Smoking Oxidants and Aberrant Ciliated Cell Function

Smoking | COPD

United States
Weill Medical College of Cornell University

Completed

Modulation of Genes Responsible for Cilia Length by Exposure to Cigarette Smoke

Smoking | COPD

United States
Arrowhead Pharmaceuticals

Recruiting

Study of ARO-RAGE in Healthy Subjects and Patients With Inflammatory Lung Disease

Asthma

Korea, Republic of, Australia, Thailand, New Zealand, Poland, Spain
Sunovion

Completed

Costs & Outcomes of Hospitalization/Treatment With Levalbuterol & Albuterol in Asthma or Chronic Obstructive Pulmonary Disease (COPD) Subjects (POLARIS)

Asthma | COPD

United States
Johns Hopkins University
Temple University; State University of New York at Buffalo

Completed

Broccoli Sprout Extracts Trial to See if NRF2 is Enhanced by Sulforaphane Treatment in Patients With COPD (BEST)

COPD

United States
The Cooper Health System

Completed

Use of Dexmedetomidine for Sedation During Flexible Bronchoscopy in Patients With COPD: A Descriptive Study

Sedation | COPD | Flexible Bronchoscopy

United States
Arrowhead Pharmaceuticals

Recruiting

Study of ARO-MUC5AC in Healthy Subjects and Patients With Muco-Obstructive Lung Disease

Chronic Obstructive Pulmonary Disease | Asthma

Korea, Republic of, Australia, New Zealand, Poland, Thailand, Spain
Institut für Pneumologie Hagen Ambrock eV

Completed

Nasal High Flow (NHF) in COPD - Effects on Ventilation in Wakefulness

COPD

Germany
Wissenschaftliches Institut Bethanien e.V
Boehringer Ingelheim; ndd Medizintechnik AG

Completed

Multiple Breath Washout as a Method for Diagnosing Lung Diseases

Asthma | Pulmonary Fibrosis | COPD

Germany

3

Subscribe